Literature DB >> 1701418

Establishment of a foreign antigen secretion system in mycobacteria.

K Matsuo1, R Yamaguchi, A Yamazaki, H Tasaka, K Terasaka, M Totsuka, K Kobayashi, H Yukitake, T Yamada.   

Abstract

In order to develop recombinant Mycobacterium bovis BCG into a useful multivaccine vehicle, we established a foreign antigen secretion system in mycobacteria in which an extracellular alpha antigen of Mycobacterium kansasii was utilized as a carrier. By using this system, a B-cell epitope (Glu-12-Leu-Asp-Arg-Trp-Glu-Lys-Ile-19) of human immunodeficiency virus type 1 p17gag, which was identified by a fusion protein-based method, has been successfully obtained from BCG along with the alpha antigen. This is the first report of expression and secretion of a foreign viral antigen from BCG. It is possible that the system can become a universal vaccination vehicle applicable to protection against various infectious diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701418      PMCID: PMC313775          DOI: 10.1128/iai.58.12.4049-4054.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Complete nucleotide sequence of immunogenic protein MPB70 from Mycobacterium bovis BCG.

Authors:  K Terasaka; R Yamaguchi; K Matsuo; A Yamazaki; S Nagai; T Yamada
Journal:  FEMS Microbiol Lett       Date:  1989-04       Impact factor: 2.742

Review 2.  Development of BCG as a recombinant vaccine vehicle.

Authors:  W R Jacobs; S B Snapper; L Lugosi; B R Bloom
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics.

Authors:  A Lotte; O Wasz-Höckert; N Poisson; N Dumitrescu; M Verron; E Couvet
Journal:  Adv Tuberc Res       Date:  1984

5.  Lysogeny and transformation in mycobacteria: stable expression of foreign genes.

Authors:  S B Snapper; L Lugosi; A Jekkel; R E Melton; T Kieser; B R Bloom; W R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

6.  Cloning and expression of the Mycobacterium bovis BCG gene for extracellular alpha antigen.

Authors:  K Matsuo; R Yamaguchi; A Yamazaki; H Tasaka; T Yamada
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

7.  Vaccinia virus: a selectable eukaryotic cloning and expression vector.

Authors:  M Mackett; G L Smith; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

8.  Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.

Authors:  D Panicali; E Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

9.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Easy identification of cDNA clones.

Authors:  U Rüther; B Müller-Hill
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  22 in total

1.  MHC-restricted Ag85B-specific CD8+ T cells are enhanced by recombinant BCG prime and DNA boost immunization in mice.

Authors:  Shihoko Komine-Aizawa; Jiansheng Jiang; Satoru Mizuno; Satoshi Hayakawa; Kazuhiro Matsuo; Lisa F Boyd; David H Margulies; Mitsuo Honda
Journal:  Eur J Immunol       Date:  2019-06-19       Impact factor: 5.532

2.  Construction of shuttle vectors for genetic manipulation and molecular analysis of mycobacteria.

Authors:  S Jain; D Kaushal; S K DasGupta; A K Tyagi
Journal:  Gene       Date:  1997-04-29       Impact factor: 3.688

Review 3.  Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.

Authors:  Rosamund Chapman; Gerald Chege; Enid Shephard; Helen Stutz; Anna-Lise Williamson
Journal:  Curr HIV Res       Date:  2010-06       Impact factor: 1.581

4.  Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guérin producing a pertussis toxin-tetanus toxin hybrid protein.

Authors:  B Abomoelak; K Huygen; L Kremer; M Turneer; C Locht
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  A recombinant BCG vaccine generates a Th1-like response and inhibits IgE synthesis in BALB/c mice.

Authors:  M Kumar; A K Behera; H Matsuse; R F Lockey; S S Mohapatra
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

6.  Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals.

Authors:  M Honda; K Matsuo; T Nakasone; Y Okamoto; H Yoshizaki; K Kitamura; W Sugiura; K Watanabe; Y Fukushima; S Haga; Y Katsura; H Tasaka; K Komuro; T Yamada; T Asano; A Yamazaki; S Yamazaki
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

7.  Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes.

Authors:  M A O'Donnell; A Aldovini; R B Duda; H Yang; A Szilvasi; R A Young; W C DeWolf
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  Molecular characterization of heterologous HIV-1gp120 gene expression disruption in mycobacterium bovis BCG host strain: a critical issue for engineering mycobacterial based-vaccine vectors.

Authors:  Joan Joseph; Raquel Fernández-Lloris; Elías Pezzat; Narcís Saubi; Pere-Joan Cardona; Beatriz Mothe; Josep Maria Gatell
Journal:  J Biomed Biotechnol       Date:  2010-06-27

9.  Cloning and expression of the gene for the Avi-3 antigen of Mycobacterium avium and mapping of its epitopes.

Authors:  R Yamaguchi; K Matsuo; A Yamazaki; M Takahashi; Y Fukasawa; M Wada; C Abe
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

10.  Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines.

Authors:  P J Murray; A Aldovini; R A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.